Hospital acquired infections are important because they cause disease, economical loss and death in hospital inpatients. These infections are difficult to treat and sometimes cause death. Thus, they count as a serious and growing risk factor that threatens the health of almost all patients who are confined in hospitals (
1). Patients, who have burn injuries, are at increased risk of hospital acquired infections, because burn wounds are suitable places to grow opportunistic bacteria, including
Pseudomonas and
Acinetobacter (
2).
Pseudomonas aeruginosa is a Gram-negative, obligate aerobic bacterium, and the most prevalent factor in hospital related infections include: pneumonia, bacteremia and serious infections in burn patients. This bacterium is ubiquitous and originates in areas such as water, soil and skin (
3-
5).
Acinetobacter baumannii is one of the most widespread bacteria found among hospital acquired infections, and it usually has a second/third rank among the prevalent pathogens of these kinds of infections (
5-
7). Infection with this bacterium is very dangerous, particularly for patients who are confined in hospitals’ intensive care units (
5,
8).
Acinetobacter may cause infection in the respiratory system, urinary tract and meningitis (
5,
9). Various types of antiseptics are utilized in hospitals and medical centers, and until now many samples of bacteria resistant to antiseptics have been reported. Resistance related to
qac, and small multidrug resistance (SMR) genes are due to resistance against DNA-intercalating dyes (like ethidium bromide) and quaternary ammonium compounds (like benzalkonium chloride), therefore, resistance mechanisms are coded by
smr,
qacE and
qacA. These gene products are transmembrane proteins (
10). Although the most frequent genes which code
smr,
qacE,
qacA, and
qacF are found in Gram-positive bacteria, only three types of these genes have been determined in Gram-negative bacteria. The
qacE gene (including its attenuated variant
qacEΔ1) is widespread in Gram-negative bacteria, mainly in Enterobacteriaceae and
Pseudomonas spp. because these genes are located in class 1 integrons, which in Gram-negative bacteria commonly harbor
qacEΔ1 (
11). The
qacΔE1 gene is a mutation of the
qacE gene, which acts as a multidrug transfer gene (
12). Although the
qac genes were named after one of their main substrates (QACs) was found, the spectrum of their activity is much broader. More than 30 lipophilic cationic compounds belonging to at least 12 different chemical classes are recognized as targets of
qac-mediated resistance (
13).